Aurobindo Pharma share gains 175% from its 52-week low; check what brokerages say

Posted by

Aurobindo Pharma stock erased early gains and fell in today’s trade as
the USFDA
issued a ‘Form 483’ with 9 observations to its subsidiary, AuroLife
Pharma’s manufacturing facility in the US.